-
-
Wall Street expects Meta’s AI agent to shape into a new revenue engine
-
Palo Alto Networks unveils AI-powered cybersecurity service using Claude, GPT models
-
Paramount Skydance stock gets $16 target reaffirmed by StoneX
-
PharmAla Biotech at Water Tower Research Virtual Insights Conference: supply moat
-
Activist Corvex seeks Whitbread board seat over strategy concerns
-
European drugmakers call for faster trials, more spending to compete with US, China
-
Nasdaq hits intraday record high as tech stocks regain footing
-
With new Macs, Apple aims to take on Microsoft, Nvidia in a rush to lower AI costs
-
Insmed stock price target maintained at $195 by Mizuho on FDA review